472 filings
Page 3 of 24
8-K
94jn7
24 Apr 23
Amendments to Articles of Incorporation or Bylaws
4:05pm
8-K
ue4a1n2d
29 Mar 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
5:04pm
UPLOAD
86loi71orqqikn6
20 Mar 23
Letter from SEC
12:00am
CORRESP
qgfi3xwhife5ijdqg
16 Mar 23
Correspondence with SEC
12:00am
UPLOAD
cmfmoy0n0o07nvtdjay
8 Mar 23
Letter from SEC
12:00am
S-8
1za5qu vq4lltwizh
6 Mar 23
Registration of securities for employees
4:22pm
8-K
udk6ta
14 Feb 23
NeuBase Therapeutics Reports Business Update and Financial Results
4:20pm
424B5
ycua576wzczhk5conkqi
29 Dec 22
Prospectus supplement for primary offering
5:03pm
8-K
ycgkdwmm6jog
29 Dec 22
Entry into a Material Definitive Agreement
4:06pm
8-K
iglgjeu
21 Dec 22
NeuBase Therapeutics Reports Business Update and Financial Results
8:10am
8-K
fa71vb0hy nh
24 Oct 22
Departure of Directors or Certain Officers
4:45pm
8-K
kgdvj kgyq883eh
14 Oct 22
NeuBase Therapeutics Announces Strategic Restructuring Focused on Advancing Its Platform in Gene Editing
4:20pm
8-K
6aq91up7b pw
3 Oct 22
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
8:15am
8-K
63ecoh 3no6w
12 Sep 22
Submission of Matters to a Vote of Security Holders
4:47pm
8-K
q8n2tn8a
11 Aug 22
NeuBase Therapeutics Reports Business Update and Financial Results for the Third Quarter of Fiscal Year 2022
8:05am
DEFA14A
919izoeq z3xayg3a
22 Jul 22
Additional proxy soliciting materials
4:36pm